Jean Shin works as an Investor at Sarissa Capital Management. The firm's known portfolio counts 4 companies.
Is Jean Shin a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
Contacts
Affiliated funds' portfolios
Investor at Sarissa Capital Management, whose known portfolio counts 4 companies
- Lyndra Therapeutics
- Pear Therapeutics
- Iterum Therapeutics
- Attralus
Investor Profile
Stage-wise, the deals at Sarissa Capital Management cluster around Growth, Late-Stage and Series B rounds.
The firm portfolio and the focus above give founders context on whether Jean Shin matches their raise.
Colleagues at Sarissa Capital Management
Frequently asked questions
Who is Jean Shin?
Jean Shin is a private equity investor and venture debt investor based in New York, United States, listed as Investor at Sarissa Capital Management. The known portfolio of that firm counts 4 companies. That portfolio belongs to the firm, not to Jean Shin personally.
What stage does Jean Shin invest at?
Sarissa Capital Management appears in Growth, Late-Stage and Series B rounds across its known deals, and Jean Shin is listed there as Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Jean Shin listed at?
Jean Shin is listed as Investor at Sarissa Capital Management. 2 other people in the database share a firm with Jean Shin.
How do I contact Jean Shin?
An email address, a phone number and a LinkedIn page are on file for Jean Shin. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal
